Replies to post #153898 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

"crush" will actually evaluate the information released before "crushing"

I would like to think the herd will not all go over the cliff (as usual) when AAIC results/presentations come in. But, maybe they will and there is not a thing anyone can do about it.

Hoping we see the significance of what is about to happen. It will not be obvious but so what. Big P failed w/AD trials b/c they were not paying attention. They repeated minor variations of the same trial in spite of contradictory evidence that Amyloid was the cause of AD. They ignored the facts. Massive amounts of money, time and lives were lost. If anyone needs a lesson on how NOT to treat AD, there it is.

Anavex is showing that the "Process is the Product". Precision Medicine is about getting your basic clinical facts clean and applying process discipline proving ties to massively complex, sub atomic complexities using AI, etal. It is not getting a 1000 patients in a room, confirm their disease, administering (XX) and wait to see what happens. AVXL will predict an outcome based on science unique to the patient, only using trials to do V&V on the predicted result. Not a trial as we know them from history. Imagine taking final exams on subjects you are competent in. You may not get A+ but will get a grade other than zero/F. Not every patient will get up and walk away, but some will.

Oncology has gone down this same path we are about to go down. The process works, the AD process being followed is fundamentally the same. Blindly selling when the results are not in is not smart. Driving sp down and buying back the next day is risky.

[LakeshoreLeo1953]

MY Evaluation is the roads in Mexico suck.

I am stuck with them for another couple days, but
they don't change my long term attitude of the trip.

That might be good counsel in AVXL.